Piper Sandler initially assigned an "shareholding" rating to abbott laboratories.
On September 20th, Piper Sandler covered Abbott Laboratories for the first time, giving it an 'overweight' rating with a target price of $131.
Abbott Laboratories To Go Ex-Dividend On October 15th, 2024 With 0.55 USD Dividend Per Share
September 19th (Eastern Time) - $Abbott Laboratories(ABT.US)$ is trading ex-dividend on October 15th, 2024.Shareholders of record on October 15th, 2024 will receive 0.55 USD dividend per share on
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
Express News | Abbott Declares 403Rd Consecutive Quarterly Dividend
Express News | Abbott - Declared a Quarterly Common Dividend of 55 Cents per Share.
Press Release: Abbott Declares 403rd Consecutive Quarterly Dividend
Abbott a New Overweight at Piper Sandler; at Attractive Entry Point
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Abbott Laboratories' (NYSE:ABT) Stock Been Rising: Are Strong Financials Guiding The Market?
Abbott Laboratories Analyst Ratings
Piper Sandler Initiates Abbott Laboratories(ABT.US) With Buy Rating, Announces Target Price $131
Piper Sandler analyst Adam Maeder initiates coverage on $Abbott Laboratories(ABT.US)$ with a buy rating, and sets the target price at $131.According to TipRanks data, the analyst has a success rate
Buy Rating on Abbott Laboratories: Undervalued With Strong Growth Prospects Despite NEC Litigation
Express News | Abbott : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $131
20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates
Express News | Sichuan Kelun Pharmaceutical: Diquinon Tablets Obtains Pharmaceutical Registration Approval.
Senseonics Eversense 365 Glucose Monitor Cleared in the U.S.
New Survey From Abbott Finds Epidemiologists Believe Viral and Mosquito-Borne Pathogens Are Priority Concerns for Disease Outbreaks
Moderna Was Most Shorted S&P 500 Healthcare Stock in August for Second Consecutive Month
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?